Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
AngioDynamics, Inc. (ANGO) had Stock-Based Compensation of $7.36M for the most recently reported fiscal quarter, ending 2025-11-30.
| Income Statement Financials | |
$79.43M |
|
$-6.35M |
|
$34.65M |
|
$44.78M |
|
$85.56M |
|
$-6.12M |
|
$-0.23M |
|
$-6.36M |
|
$-6.36M |
|
$-6.35M |
|
$-6.35M |
|
$-6.35M |
|
$-6.35M |
|
$-6.12M |
|
$-0.38M |
|
41.54M |
|
41.54M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$161.35M |
|
$30.53M |
|
$108.33M |
|
$269.68M |
|
$71.96M |
|
-- |
|
$21.39M |
|
$93.35M |
|
$176.33M |
|
$109.60M |
|
$176.33M |
|
41.57M |
|
| Cash Flow Statement Financials | |
$-11.25M |
|
$-3.17M |
|
$0.05M |
|
$55.89M |
|
$41.64M |
|
$-14.26M |
|
|
Stock-Based Compensation |
$7.36M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.38% |
|
-7.71% |
|
-7.71% |
|
-- |
|
-8.00% |
|
-7.99% |
|
$-12.41M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.53 |
|
1.79 |
|
50.35 |
|
-3.60% |
|
-5.79% |
|
-2.35% |
|
-3.60% |
|
$4.24 |
|
$-0.30 |
|
$-0.27 |
|